Products containing more than 0.2% THC are not legally available in the UK.
Whilst the studies in the laboratory show some promise, we need to understand the wider effects that these components have before we can know whether they have any effect – positive or negative – on the development of Alzheimer’s in people.
What is Cannabidiol (CBD)?
There are no research studies that prove cannabis, or products such as cannabis oil (CBD oil), can stop, slow, reverse or prevent the diseases that cause dementia.
Read our advice to help reduce your risk of developing dementia.
Currently there is no evidence to show that cannabis or cannabis oil (CBD oil) can stop, reverse or prevent dementia.
Methods: Eleven AD patients were recruited to an open label, 4 weeks, prospective trial.
Objective: To measure efficacy and safety of medical cannabis oil (MCO) containing THC as an add-on to pharmacotherapy, in relieving behavioral and psychological symptoms of dementia (BPSD).
Results: Ten patients completed the trial. Significant reduction in CGI severity score (6.5 to 5.7; p < 0.01) and NPI score were recorded (44.4 to 12.8; p < 0.01). NPI domains of significant decrease were: Delusions, agitation/aggression, irritability, apathy, sleep and caregiver distress.
Conclusion: Adding MCO to AD patients’ pharmacotherapy is safe and a promising treatment option.
Background: Tetrahydrocannabinol (THC) is a potential treatment for Alzheimer’s disease (AD).
Keywords: Alzheimer’s disease; behavioral and psychological symptoms of dementia; cannabis; tetrahydrocannabinol.
In addition to the foregoing, the Company provides the following update to the previously announced matter with one of its subsidiaries, Global NV Corporation (“GNV”). As reported, GNV received a claim from a former landlord with respect to a commercial lease agreement entered into by GNV in October 2018 (the “Lease”). The Lease was abandoned by GNV in January 2019 due to Adams County Fire Department identifying the need for upgraded sprinkler systems that were not highlighted by the landlord as being required for the type of operation when GNV took possession of the property. Neither the landlord or GNV believed it was their responsibility to improve the facility as required by Adams County FD. The landlord under the Lease seeks to recover from GNV unpaid lease payments for the remainder of the Lease period (subject to mitigation) in the gross claimed amount of $550,000 plus fees. Management of GNV is vigorously defending the claim. To date, the Landlord has become an aggressive creditor pushing the Company to file for protection under the Chapter 11 (subsection(v)) bankruptcy laws in the United States for the subsidiary company, allowing the subsidiary to reorganize its debt and present a plan for GNV’s continued operations. Formal documents were filed for Global NV and its subsidiary Strasburg Pharms on March 23, 2021. CBD Global, GNV’s parent company, has a vested interest in successfully navigating through this matter despite the creditor’s claims.
For the first time, investigators report that CBD treatments normalized the levels of these proteins. CBD also helped to improve cognitive function in mice with a form of early onset familial Alzheimer’s disease. Dr. Babak Baban, an immunologist and associate dean for research in the Dental College of Georgia, says CBD helped to reduce levels of IL-6. Researchers believe this particular immune protein has a link to high levels of inflammation in Alzheimer’s patients. (Source: Study Finds)
ABOUT CBD GLOBAL SCIENCES INC.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Cannabidiol, or CBD, continues to gain support as a remedy for everything from stress to bacterial infections. A new study reveals marijuana’s non-psychoactive ingredient may also be the key to stopping the triggers for Alzheimer’s disease. Researchers from the Medical College of Georgia at Augusta University say high doses of CBD restores the function of key proteins that clean up beta-amyloid plaque buildups in the brain. These clumps are one of the major causes of Alzheimer’s disease, the most common form of dementia.
CBD Global Sciences, Inc., is a vertically integrated hemp-based CBD producer and branding investment vehicle which currently owns two product categories, branded under the name Aethics™ (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, Hydration products and Confectionary products. CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.
March 25, 2021 07:30 ET | Source: CBD Global Sciences Inc. CBD Global Sciences Inc.